Glucocorticoid Receptor Signaling Impairs Protein Turnover Regulation in Hypoxia-Induced Muscle Atrophy in Male Mice

Hypoxemia may contribute to muscle wasting in conditions such as chronic obstructive pulmonary disease. Muscle wasting develops when muscle proteolysis exceeds protein synthesis. Hypoxia induces skeletal muscle atrophy in mice, which can in part be attributed to reduced food intake. We hypothesized that hypoxia elevates circulating corticosterone concentrations by reduced food intake and enhances glucocorticoid receptor (GR) signaling in muscle, which causes elevated protein degradation signaling and dysregulates protein synthesis signaling during hypoxia-induced muscle atrophy. Muscle-specific GR knockout and control mice were subjected to normoxia, normobaric hypoxia (8% oxygen), or pair-feeding to the hypoxia group for 4 days. Plasma corticosterone and muscle GR signaling increased after hypoxia and pair-feeding. GR deficiency prevented muscle atrophy by pair-feeding but not by hypoxia. GR deficiency differentially affected activation of ubiquitin 26S-proteasome and autophagy proteolytic systems by pair-feeding and hypoxia. Reduced food intake suppressed mammalian target of rapamycin complex 1 (mTORC1) activity under normoxic but not hypoxic conditions, and this retained mTORC1 activity was mediated by GR. We conclude that GR signaling is required for muscle atrophy and increased expression of proteolysis-associated genes induced by decreased food intake under normoxic conditions. Under hypoxic conditions, muscle atrophy and elevated gene expression of the ubiquitin proteasomal system-associated E3 ligases Murf1 and Atrogin-1 are mostly independent of GR signaling. Furthermore, impaired inhibition of mTORC1 activity is GR-dependent in hypoxia-induced muscle atrophy.

[1]  Sangeeta Khare,et al.  Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .

[2]  A. Goldberg,et al.  Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy , 2015, Nature Communications.

[3]  F. Britto,et al.  REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy. , 2014, American journal of physiology. Endocrinology and metabolism.

[4]  K. Nair,et al.  Fasting Increases Human Skeletal Muscle Net Phenylalanine Release and This Is Associated with Decreased mTOR Signaling , 2014, PloS one.

[5]  Zaki K Hassan-Smith,et al.  11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess , 2014, Proceedings of the National Academy of Sciences.

[6]  A. Schols,et al.  Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. , 2013, The international journal of biochemistry & cell biology.

[7]  M. Párraga,et al.  Effect of normobaric hypoxia on the testis in a murine model , 2013, Andrologia.

[8]  F. Hoffmann,et al.  Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo. , 2013, Molecular endocrinology.

[9]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[10]  W. Lamers,et al.  Distinct responses of protein turnover regulatory pathways in hypoxia- and semistarvation-induced muscle atrophy. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[11]  C. Gondro,et al.  Impact of fasting on the rhythmic expression of myogenic and metabolic factors in skeletal muscle of adult mice. , 2013, American journal of physiology. Cell physiology.

[12]  M. Sandri,et al.  Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.

[13]  Shakir Ali,et al.  Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin–proteasome pathway and calpains , 2012, Molecular and Cellular Biochemistry.

[14]  F. Costes,et al.  Hypoxia and muscle maintenance regulation: implications for chronic respiratory disease , 2011, Current opinion in clinical nutrition and metabolic care.

[15]  I. Simpson,et al.  REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade. , 2011, Biochemical and biophysical research communications.

[16]  R. Hoffmann,et al.  Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells , 2011, European Respiratory Journal.

[17]  S. Matsuyama,et al.  Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in Lymphocytes* , 2011, The Journal of Biological Chemistry.

[18]  Keiichi Fukuda,et al.  Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.

[19]  D. Allen,et al.  Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli , 2011, Molecular and Cellular Endocrinology.

[20]  M. Shibamori,et al.  DNA binding - dependent glucocorticoid receptor activity promotes adipogenesis via krüppel-like factor 15 gene expression , 2010, Laboratory Investigation.

[21]  J. Cidlowski,et al.  Phosphatidylinositol 3-kinase interacts with the glucocorticoid receptor upon TLR2 activation , 2009, Journal of cellular and molecular medicine.

[22]  F. Maltais,et al.  Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD , 2010, Thorax.

[23]  S. Rothman How is the balance between protein synthesis and degradation achieved? , 2010, Theoretical Biology and Medical Modelling.

[24]  M. Sandri Autophagy in skeletal muscle , 2010, FEBS letters.

[25]  Kathryn G. Foster,et al.  Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony* , 2010, The Journal of Biological Chemistry.

[26]  R. Blitzer,et al.  REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. , 2010, Endocrinology.

[27]  J. Ruijter,et al.  Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification* , 2010, The Journal of Biological Chemistry.

[28]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[29]  D. Fingar,et al.  mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action* , 2009, The Journal of Biological Chemistry.

[30]  W. Mitch,et al.  Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. , 2009, The Journal of clinical investigation.

[31]  P. Walsh,et al.  Identification of two glucocorticoid response elements in the promoter region of the ubiquitous isoform of glutamine synthetase in gulf toadfish, Opsanus beta. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  Sierra M. Smith FoxO1 induces apoptosis in skeletal myotubes , 2009 .

[33]  F. Buttgereit,et al.  Genomic and nongenomic effects of glucocorticoids , 2008, Nature Clinical Practice Rheumatology.

[34]  D. Sgroi,et al.  Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.

[35]  A. Russell,et al.  Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[36]  D. Attaix,et al.  Myostatin Gene Deletion Prevents Glucocorticoid- Induced Muscle Atrophy , 2022 .

[37]  L. Ellisen,et al.  Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1* , 2006, Journal of Biological Chemistry.

[38]  C. Proud,et al.  The mTOR pathway in the control of protein synthesis. , 2006, Physiology.

[39]  M. Decramer,et al.  Systemic effects of COPD. , 2005, Respiratory medicine.

[40]  D. Glass,et al.  Skeletal muscle hypertrophy and atrophy signaling pathways. , 2005, The international journal of biochemistry & cell biology.

[41]  H. Esumi,et al.  Involvement of Transforming Growth Factor-β1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation* , 2005, Journal of Biological Chemistry.

[42]  M. Leonard,et al.  Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor1 , 2005, The Journal of Immunology.

[43]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[44]  J. Jorcano,et al.  Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. , 2004, Molecular endocrinology.

[45]  M. Engelen,et al.  Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[46]  A. Klippel,et al.  Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4 , 2003, Oncogene.

[47]  Hiroshi Nakamura,et al.  Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression* , 2003, Journal of Biological Chemistry.

[48]  S. Bhasin,et al.  Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. , 2003, American journal of physiology. Endocrinology and metabolism.

[49]  S. Israels,et al.  BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF , 2003, Oncogene.

[50]  A. Goldberg,et al.  Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[52]  H. van Essen,et al.  Pharmacokinetic advantage of intrapericardially applied substances in the rat. , 2002, The Journal of pharmacology and experimental therapeutics.

[53]  T. Yoneda,et al.  Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease. , 2001, Nutrition.

[54]  D. Giussani,et al.  Plasma Adrenocorticotropin and Cortisol Concentrations during Acute Hypoxemia after a Reversible Period of Adverse Intrauterine Conditions in the Ovine Fetus During Late Gestation**This work was supported by the British Heart Foundation. , 2001, Endocrinology.

[55]  R. Casaburi Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.

[56]  D. Giussani,et al.  Plasma adrenocorticotropin and cortisol concentrations during acute hypoxemia after a reversible period of adverse intrauterine conditions in the ovine fetus during late gestation. , 2001, Endocrinology.

[57]  E. Wouters,et al.  Nutrition and metabolism in COPD. , 2000, Chest.

[58]  J. Haspel,et al.  Selective expression of Cre recombinase in skeletal muscle fibers , 2000, Genesis.

[59]  O. Kretz,et al.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.

[60]  E. Wouters,et al.  Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function , 1998, European Journal of Clinical Nutrition.

[61]  F. Dela,et al.  The effect of altitude hypoxia on glucose homeostasis in men , 1997, The Journal of physiology.

[62]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[63]  A. Goldberg,et al.  Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.

[64]  A. Goldberg,et al.  Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.

[65]  S. Mason,et al.  Fluorimetric detection of serum corticosterone using high-performance liquid chromatography. , 1992, Journal of chromatography.

[66]  M. Sporn,et al.  Hypoxia upregulates the synthesis of tgf-β1 by human dermal fibroblasts , 1991 .

[67]  M. Sporn,et al.  Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. , 1991, The Journal of investigative dermatology.

[68]  B. T. Jackson,et al.  Adrenal secretion of glucocorticoids during hypoxemia in fetal sheep. , 1989, Endocrinology.

[69]  P. Gluckman,et al.  Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation. , 1989, Endocrinology.

[70]  E. Hartsook,et al.  Effects of fasting on muscle protein turnover, the composition of weight loss, and energy balance of obese and nonobese Zucker rats. , 1982, The Journal of nutrition.

[71]  S. Gruenau,et al.  Cross-adaptive effects of cold, hypoxia, or physical training on decompression sickness in mice. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[72]  R. N. Hardy,et al.  Adrenal and pancreatic endocrine responses to hypoxia in the conscious calf. , 1976, The Journal of physiology.

[73]  F. Moncloa,et al.  ENDOCRINE STUDIES AT HIGH ALTITUDE , 1968 .